Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GABPB1 intronic transcript 1 (GABPB1-IT1) is a long non-coding RNA (lncRNA) transcribed from the GABPB1 genomic locus on human chromosome 15[5]. It is not translated into a protein, but fulfills important regulatory roles at the RNA level. GABPB1-IT1 is primarily involved in the regulation of the cell cycle and DNA-associated processes, including chromatid cohesion, mitotic division, and DNA replication[2]. The lncRNA also acts as a microRNA sponge—most notably for miR-93—enabling the upregulation of miR-93 targets such as pigment epithelium-derived factor (PEDF)[4]. Lower expression of GABPB1-IT1 has been linked to increased cancer cell proliferation and poor survival in multiple cancers, suggesting its utility as a prognostic biomarker but not as a direct therapeutic target. No direct drug interactions or therapeutic interventions targeting GABPB1-IT1 are currently known[2][3][4][5].
Acts as a competitive endogenous RNA ("sponge") that binds and sequesters specific microRNAs such as miR-93, thereby indirectly upregulating targets of these miRNAs (e.g., pigment epithelium-derived factor/PEDF)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GABPB1 intronic transcript 1 (GABPB1-IT1).